DEFENCE THERAPEUTICS, STRONG THERAPEUTICS PIPELINE: ADC's, CANCER AND COVID VACCINES
ADC's, CANCER AND COVID VACCINES Vancouver, BC, Canada, May 18, 2021 - Defence Therapeutics Inc. (" Defence" or the " Company"), a Canadian biotech Company focused on the development of novel and highly specific vaccines and antibody-drug conjugates targeting cancer and infectious diseases is pleased to begin its trading under the symbol DTC as of today. The primary objective and business of Defence is the research, development and advancement of three main products using its proprietary Accum technology: - Dendritic Cell (DC) cancer vaccines using Accum (Accuvac TM). - ADCs (Antibody Drug C...